Evidence map›Paper›PMID 34094110›Full record

ArticleChemical science2020

Strategies for remote enantiocontrol in chiral gold(iii) complexes applied to catalytic enantioselective γ,δ-Diels-Alder reactions.

Jolene P Reid, Mingyou Hu, Susumu Ito, Banruo Huang, Cynthia M Hong, Hengye Xiang, Matthew S Sigman, F Dean Toste

Abstract read
In one paragraph

Article in Chemical science, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Current Developments ofBiomedicines · 2022
    Review
  6. Article
  7. Review
  8. Review
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Jolene P ReidDepartment of Chemistry, University of Utah 315 South 1400 East Salt Lake City Utah 84112 USA matt.sigman@utah.edu.ORCID https://orcid.org/0000-0003-2397-0053
Mingyou HuDepartment of Chemistry, University of California Berkeley California 94720 USA fdtoste@berkeley.edu.
Susumu ItoDepartment of Chemistry, University of California Berkeley California 94720 USA fdtoste@berkeley.edu.
Banruo HuangDepartment of Chemistry, University of California Berkeley California 94720 USA fdtoste@berkeley.edu.
Cynthia M HongDepartment of Chemistry, University of California Berkeley California 94720 USA fdtoste@berkeley.edu.
Hengye XiangDepartment of Chemistry, University of California Berkeley California 94720 USA fdtoste@berkeley.edu.
Matthew S SigmanDepartment of Chemistry, University of Utah 315 South 1400 East Salt Lake City Utah 84112 USA matt.sigman@utah.edu.
F Dean TosteDepartment of Chemistry, University of California Berkeley California 94720 USA fdtoste@berkeley.edu.ORCID https://orcid.org/0000-0001-8018-2198

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The use of chiral square planar gold(iii) complexes to access enantioenriched products has rarely been applied in asymmetric catalysis. In this context, we report a mechanistic and synthetic investigation into the use of N-heterocyclic (NHC) gold(iii) complexes in γ,δ-Diels-Alder reactions of 2,4-dienals with cyclopentadiene. The optimal catalyst bearing a unique 2-chloro-1-naphthyl substituent allowed efficient synthesis of functionally rich carbocycles in good yields, diastereo- and enantioselectivities. Transition state and multivariate linear regression (MLR) analysis of both catalyst and substrate trends using molecular descriptors derived from designer parameter acquisition platforms, reveals attractive non-covalent interactions (NCIs) to be key selectivity determinates. These analyses demonstrate that a putative π-π interaction between the substrate proximal double bond and the catalyst aromatic group is an essential feature for high enantioselectivity.

Identifiers

PMID34094110
PMCPMC8152632

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.